Project Structure

Home  /  About us  /  Project Structure

The management structure of PhenoMeNal consists of:

  • Project Coordinator : Channel of communication between the European Commission (EC and the project partners.
  • General Assembly:  Consists of one representative from each partner and is responsible for the overall strategic direction of the project. 
  • Management Committee: Composed of a chairperson and leaders for the different activities The committee is responsible for the policy definition of the project and general scientific and strategic management of PhenoMeNal:
    1. Networking Activities – Prof. Susanna-Assunta Sansone 
    2. Service Activities – Prof. Christoph Steinbeck 
    3. Joint Research Activities – Prof. Robert Glen
  • Autonomous advisory bodies:  Panel of experts who review PhenomeNal activities and provide feedback and scientific advice to the project consortium.

Scientific and Technological Advisory Board (STAB)

Includes worldwide experts in the field of metabolomics, genomics, bioinformatics, clinical medicine and privacy and ethics. 



Dr. Theodore Alexandrov

European Molecular Biology Laboratory, Heidelberg

Prof. Sabine Bahn

Department of Chemical Engineering and Biotechnology, University of Cambridge

Prof. Murielle Bochud

Institut universitaire de médecine sociale et préventive, Lausanne

Prof. Hannelore Daniel

Molecular Nutrition Unit, Technical University of München

Prof. Rima Kaddurah-Daouk

Department of Psychiatry / Behavioral Medicine, Duke Psychiatry and Behavioral Sciences, Duke University School of Medicine

Prof.  Whei-Mei Teresa Fan

Toxicology and Cancer Biology, University of Kentucky College of Medicine

Dr. Jules Griffin

MRC Human Nutrition Research, Cambridge

Dr. Heidi Howard

Centre for Research Ethics & Bioethics, Uppsala University

Dr. Martin Ingelsson

Department of Public Health and Caring Sciences, Geriatrics; Molecular Geriatrics / Rudbeck laboratory, Uppsala University

Prof. Oliver Kohlbacher

Applied Bioinformatics Group, University of Tübingen

Prof. Barend Mons

Netherlands Bioinformatics Centre

Prof Ute Roessner

School of BioSciences, University of Melbourne, Australia

Dr. Nicolas Schauer

Metabolomic Discoveries, Germany

Prof. David Wishart

Departments of Biological Sciences and Computing Science, University of Alberta 


The User Group

Identified users in the research community to provide feedback of the tools, workflows and data resources.

The Industrial Panel

Representatives from phenotyping, genotyping and bioinformatics domain within pharmaceutical and bio-instrumentation companies. 



Michael Rodamer, Agilent Technologies

Robert Tonge, Waters

Martin Buratti, Biocrates

Michael Heiser, Metabolomics Discoveries

Manfred Spraul, Bruker

Mojgan Masoodi, Nestle 


The Stakeholder Panel

Representatives from other infrastructure initiatives, systems biology, metabolomics experts and industry panel.